# PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus

> **NCT04496401** · PHASE4 · COMPLETED · sponsor: **Nantes University Hospital** · enrollment: 25 (actual)

## Conditions studied

- Kidney Transplantation
- Pancreas Transplantation
- Diabetes

## Interventions

- **DRUG:** Tacrolimus and Tacrolimus Extended Release Oral Tablet [Envarsus]

## Key facts

- **NCT ID:** NCT04496401
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-28
- **Primary completion:** 2023-11-07
- **Final completion:** 2023-11-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-12-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496401, "PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT04496401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*